UK records nearly 200 deaths linked to Ozempic, Mounjaro and other weight-loss drugs
UK health authorities have documented close to 200 fatalities associated with popular anti-obesity medications. Tirzepatide, sold as Mounjaro, accounts for the highest toll with 120 deaths and over 106,000 adverse reactions reported. Semaglutide, marketed as Ozempic and Wegovy, has been linked to 59 deaths, while liraglutide, known as Saxenda, is tied to 37 fatalities. Collectively, these drugs have been associated with more than 150,000 adverse effects across the UK.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)
Log in to join the discussion and vote.
Log in